Itch relief drug study halted early
NCT ID NCT06773403
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study tested the drug upadacitinib in adults with moderate-to-severe prurigo nodularis, a condition causing very itchy skin bumps. The goal was to see if it could reduce itching over 24 weeks. Only 5 people took part before the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRURIGO NODULARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eczema Treatment Center of New Jersey
East Windsor, New Jersey, 08520, United States
Conditions
Explore the condition pages connected to this study.